Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul H Huang

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
Expert Review of Anticancer Therapy|November 8, 2016
Targeting SWI/SNF mutant cancers with tyrosine kinase inhibitor therapyPaul H Huang
Molecular Biosystems|December 3, 2011
Phosphoproteomic studies of receptor tyrosine kinases: future perspectivesPaul H Huang
Molecular Omics|October 9, 2020
Data-independent acquisition mass spectrometry (DIA-MS) for proteomic applications in oncologyLukas Krasny, Paul H Huang
Current Treatment Options in Oncology|February 16, 2022
Proteomic and Metabolomic Profiling in Soft Tissue SarcomasMadhumeeta Chadha, Paul H Huang
Methods in Molecular Biology (Clifton, N.J.)|July 22, 2017
Analysis of Phosphotyrosine Signaling Networks in Lung Cancer Cell LinesMalgorzata Broncel, Paul H Huang
Expert Review of Proteomics|October 22, 2021
Advances in the proteomic profiling of the matrisome and adhesomeLukas Krasny, Paul H Huang
Expert Review of Anticancer Therapy|December 16, 2021
Amivantamab for the treatment of <i>EGFR</i> exon 20 insertion mutant non-small cell lung cancerSimon Vyse, Paul H Huang
Signal Transduction and Targeted Therapy|March 12, 2019
Targeting <i>EGFR</i> exon 20 insertion mutations in non-small cell lung cancerSimon Vyse, Paul H Huang
Nature|May 22, 2009
Cancer: Melanoma troops massedPaul H Huang, Richard Marais
Seminars in Cancer Biology|February 25, 2020
Translational genomics for rare cancers: Challenges and opportunityAik Choon Tan, Paul H Huang
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
Expert Review of Anticancer Therapy|November 8, 2016
Targeting SWI/SNF mutant cancers with tyrosine kinase inhibitor therapyPaul H Huang
Molecular Biosystems|December 3, 2011
Phosphoproteomic studies of receptor tyrosine kinases: future perspectivesPaul H Huang
Molecular Omics|October 9, 2020
Data-independent acquisition mass spectrometry (DIA-MS) for proteomic applications in oncologyLukas Krasny, Paul H Huang
Current Treatment Options in Oncology|February 16, 2022
Proteomic and Metabolomic Profiling in Soft Tissue SarcomasMadhumeeta Chadha, Paul H Huang
Methods in Molecular Biology (Clifton, N.J.)|July 22, 2017
Analysis of Phosphotyrosine Signaling Networks in Lung Cancer Cell LinesMalgorzata Broncel, Paul H Huang
Expert Review of Proteomics|October 22, 2021
Advances in the proteomic profiling of the matrisome and adhesomeLukas Krasny, Paul H Huang
Expert Review of Anticancer Therapy|December 16, 2021
Amivantamab for the treatment of <i>EGFR</i> exon 20 insertion mutant non-small cell lung cancerSimon Vyse, Paul H Huang
Signal Transduction and Targeted Therapy|March 12, 2019
Targeting <i>EGFR</i> exon 20 insertion mutations in non-small cell lung cancerSimon Vyse, Paul H Huang
Nature|May 22, 2009
Cancer: Melanoma troops massedPaul H Huang, Richard Marais
Seminars in Cancer Biology|February 25, 2020
Translational genomics for rare cancers: Challenges and opportunityAik Choon Tan, Paul H Huang
Pageof 10